GO:1905890 regulation of cellular response to very-low-density lipoprotein particle stimulus: VLDL Signaling Control, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1905890 describes any biological process that modulates the frequency, rate, or extent of a cell's response to a very-low-density lipoprotein (VLDL) particle stimulus.
• VLDL particles are apolipoprotein B (APOB)-containing lipoproteins, and apolipoprotein B-containing lipoproteins are a major regulator of neutrophil responses to monosodium urate crystals.
• The term sits within the biological_process ontology and is the regulatory parent of the cellular response to VLDL particle stimulus.
• Because VLDL is a metabolic and inflammatory signal, its regulation intersects with lipid handling, innate immune activation, and crystal-induced inflammation.
• Studying GO:1905890 requires models that separate VLDL particle exposure from downstream cellular activation, ideally with CRISPR knockout, knock-in, or overexpression of candidate regulators.
• The verified literature directly linking APOB-containing lipoproteins to neutrophil regulation provides the strongest current anchor for this GO term.
Description
GO:1905890, regulation of cellular response to very-low-density lipoprotein particle stimulus, is a Gene Ontology biological_process term that captures the control layer acting on how cells respond when they encounter very-low-density lipoprotein (VLDL) particles. Rather than describing the response itself, this term describes the modulatory processes that set the frequency, rate, or extent of that response. In practical terms, it is the difference between a cell detecting VLDL and the cell's machinery deciding how strongly, how quickly, and for how long to react. This distinction matters because VLDL is not merely a lipid transport vehicle; apolipoprotein B-containing lipoproteins have been shown to be a major regulator of neutrophil responses to monosodium urate crystals, linking lipoprotein biology directly to innate immune cell behavior. Researchers annotating or interrogating GO:1905890 therefore need to think about both the VLDL particle stimulus and the regulatory nodes that tune the cellular reaction to it. The term is especially relevant for studies of metabolic inflammation, where lipoprotein particles and immune cells converge. Because the QuickGO definition is deliberately broad, experimental work must define the specific cell type, the VLDL preparation, and the readout of the cellular response being modulated.
regulation of cellular response to very-low-density lipoprotein particle stimulus At A Glance
| GO ID | GO:1905890 |
|---|---|
| GO term | regulation of cellular response to very-low-density lipoprotein particle stimulus |
| Ontology | biological_process |
| Synonym | regulation of cellular response to VLDL particle stimulus |
| Definition | Any process that modulates the frequency, rate or extent of cellular response to very-low-density lipoprotein particle stimulus. |
| Major function | Control of the amplitude, timing, or extent of a cell's reaction to VLDL particles. |
| Related stimulus | Very-low-density lipoprotein (VLDL) particle, an apolipoprotein B-containing lipoprotein. |
| Key literature anchor | APOB-containing lipoproteins regulate neutrophil responses to monosodium urate crystals. |
| Research relevance | Links lipoprotein metabolism with innate immune cell regulation and crystal-induced inflammation. |
What Is GO:1905890?
In our own words, GO:1905890 refers to any process that modulates the frequency, rate, or extent of the cellular response to a very-low-density lipoprotein particle stimulus. It is a regulation term, meaning it does not itself execute the response; instead, it controls how the response unfolds. The synonym regulation of cellular response to VLDL particle stimulus reflects the same concept using the common abbreviation VLDL. The term belongs to the biological_process aspect of the Gene Ontology and is defined relative to the cellular response to VLDL particle stimulus. Because the definition is process-relative, annotations under GO:1905890 should describe modulatory events, such as changes in signaling amplitude, duration, or threshold, rather than the primary VLDL-binding or lipid-uptake steps themselves.
Why Is regulation of cellular response to very-low-density lipoprotein particle stimulus Important in Cell Biology?
GO:1905890 is important because it formalizes the control layer between a metabolic lipoprotein stimulus and the cellular response that follows. Apolipoprotein B-containing lipoproteins, which include VLDL, are a major regulator of neutrophil responses to monosodium urate crystals, so understanding this regulatory term helps explain how lipoprotein particles shape innate immune activation. For researchers, the term provides an ontology anchor for experiments that ask not simply whether a cell responds to VLDL, but how that response is tuned. This is directly relevant to metabolic inflammation, where the same lipoprotein particle can be a nutrient carrier and an immune modulator depending on context. Because the definition is regulatory rather than structural, it also encourages careful experimental design: a knockout or inhibitor that changes a VLDL response readout may act on the regulatory process described by GO:1905890 rather than on VLDL binding itself.
• Provides a formal ontology label for the control of cellular responses to VLDL particles.
• Connects lipoprotein metabolism to innate immune cell regulation, as shown for APOB-containing lipoproteins and neutrophils.
• Helps distinguish VLDL sensing from VLDL response modulation in experimental interpretation.
• Supports annotation of genes that tune the magnitude or duration of VLDL-triggered signaling.
• Relevant to crystal-induced inflammation because APOB-containing lipoproteins regulate neutrophil responses to monosodium urate crystals.
• Useful for metabolic inflammation research where VLDL particles act as both lipid carriers and signaling inputs.
• Guides CRISPR study design by separating regulators from downstream effectors.
• Encourages cell-type-specific analysis, since the regulatory process may differ between neutrophils and other cells.
• Provides a framework for comparing VLDL particle stimuli with other lipoprotein stimuli in pathway analysis.
• Supports drug-target hypothesis generation around lipoprotein-immune crosstalk.
What Happens During regulation of cellular response to very-low-density lipoprotein particle stimulus?
Recognition of the VLDL particle stimulus
In simple terms: First, the cell encounters a VLDL particle and recognizes it as a signal.
The regulatory process described by GO:1905890 begins upstream of the response itself, when a cell is exposed to a very-low-density lipoprotein particle stimulus. VLDL is an apolipoprotein B-containing lipoprotein, and apolipoprotein B-containing lipoproteins have been shown to be a major regulator of neutrophil responses to monosodium urate crystals. This means the particle is not a passive lipid cargo but an input that can set the stage for a cellular reaction. The regulatory layer captured by GO:1905890 determines how that input is translated into a response.
Modulation of response amplitude
In simple terms: The cell decides how strong its reaction to VLDL should be.
Once the VLDL particle stimulus is present, the frequency, rate, or extent of the cellular response can be modulated. In the context of apolipoprotein B-containing lipoproteins, this modulation has been observed in neutrophil responses to monosodium urate crystals, where the lipoprotein context changes the cellular reaction. GO:1905890 therefore covers processes that increase or decrease the strength of the response without necessarily being the response itself. This distinction is important for annotating genes that act as rheostats rather than switches.
Temporal control of the response
In simple terms: The cell also controls how long the reaction lasts.
Regulation in GO:1905890 includes the timing of the cellular response to VLDL particles, not just its magnitude. Because the definition explicitly mentions frequency and rate, processes that delay, accelerate, or terminate the response fall under this term. The verified literature on APOB-containing lipoproteins and neutrophil responses supports the idea that lipoprotein context can shape the kinetics of an inflammatory reaction. Experimental systems that measure time-resolved readouts are therefore well suited to studying this term.
Integration with inflammatory signaling
In simple terms: VLDL regulation can be wired into the cell's inflammatory circuits.
The regulation of cellular responses to VLDL particles can intersect with inflammatory signaling, as illustrated by the finding that apolipoprotein B-containing lipoproteins are a major regulator of neutrophil responses to monosodium urate crystals. This places GO:1905890 at a crossroads between lipoprotein metabolism and innate immune activation. Researchers studying this term should therefore consider inflammatory readouts alongside lipid-handling readouts. The ontology term itself remains stimulus-specific, but its biological context can be immunometabolic.
Cell-type specificity of regulation
In simple terms: Different cells may regulate their VLDL response differently.
GO:1905890 does not specify a single cell type, and the verified evidence comes from neutrophils responding to monosodium urate crystals in the presence of apolipoprotein B-containing lipoproteins. This suggests that the regulatory process may be cell-type specific and context dependent. When designing experiments, researchers should define the cell model and the VLDL particle preparation explicitly. Such precision helps ensure that observed effects are attributed to the regulatory process rather than to unrelated cellular differences.
Key Genes Involved in GO:1905890 regulation of cellular response to very-low-density lipoprotein particle stimulus
The following genes and proteins are relevant to the biology surrounding GO:1905890, with APOB-containing lipoprotein biology providing the strongest verified link to cellular regulation.
| Gene | Major Role | Research Relevance |
|---|---|---|
| APOB | Core apolipoprotein of VLDL and other apolipoprotein B-containing lipoproteins | Central to the VLDL particle stimulus and to the regulation of neutrophil responses by APOB-containing lipoproteins |
| APOE | Apolipoprotein associated with lipoprotein metabolism | Relevant to lipoprotein particle handling and downstream cellular responses |
| VLDLR | Receptor for very-low-density lipoprotein | Candidate mediator of cellular recognition of VLDL particles |
| LRP1 | Endocytic receptor for multiple lipoproteins | Potential route for VLDL particle uptake and response modulation |
| LRP8 | LDL receptor family member | Possible contributor to lipoprotein-stimulated cellular signaling |
| LDLR | Canonical lipoprotein receptor | Comparator for VLDL-specific versus general lipoprotein responses |
| SCARB1 | Scavenger receptor for lipoproteins | Candidate for VLDL particle interaction and response regulation |
| CD36 | Scavenger receptor with lipid and lipoprotein ligands | Potential modulator of cellular responses to lipoprotein particles |
| TLR4 | Innate immune receptor | Relevant to inflammatory signaling that may intersect with lipoprotein regulation |
| NLRP3 | Inflammasome sensor | Connected to crystal-induced inflammation where APOB-containing lipoproteins regulate neutrophils |
| IL1B | Pro-inflammatory cytokine | Downstream readout of inflammatory responses modulated by lipoprotein context |
| CXCL8 | Neutrophil chemoattractant | Potential readout of neutrophil regulation by APOB-containing lipoproteins |
| SREBF1 | Lipid metabolism transcription factor | Candidate regulator of cellular lipid handling during VLDL responses |
| SREBF2 | Cholesterol metabolism transcription factor | Candidate regulator of lipoprotein-responsive gene programs |
| PPARG | Nuclear receptor in lipid and inflammatory control | Potential integrator of lipoprotein and inflammatory signals |
| NFKB1 | Inflammatory transcription factor | Candidate node linking VLDL context to inflammatory gene expression |
| MAPK1 | Signaling kinase | Potential mediator of cellular response amplitude |
| AKT1 | Signaling kinase | Potential mediator of cellular response duration and survival |
How Is regulation of cellular response to very-low-density lipoprotein particle stimulus Regulated?
Regulation of GO:1905890 is conceptually the process of controlling the cellular response to VLDL particles, and the verified literature indicates that apolipoprotein B-containing lipoproteins are a major regulator of neutrophil responses to monosodium urate crystals. This implies that the regulatory input can come from the lipoprotein particle itself, which acts as a context-setting signal rather than a simple nutrient. Because the QuickGO definition is broad, additional regulatory layers such as signaling kinases, transcription factors, and metabolic sensors are plausible but should be described generically unless supported by the verified citation. Researchers should treat GO:1905890 as a regulatory node whose activity is measured by changes in the frequency, rate, or extent of a VLDL-triggered cellular response.
regulation of cellular response to very-low-density lipoprotein particle stimulus and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| APOB | Crystal-induced neutrophil inflammation and lipoprotein regulation | APOB knockout or knockdown in neutrophil-like cells followed by monosodium urate crystal stimulation |
| NLRP3 | Inflammasome-driven inflammation in crystal responses | NLRP3 knockout cells with VLDL particle co-stimulation |
| IL1B | Cytokine output in crystal-induced inflammation | IL1B reporter knock-in for response amplitude measurement |
| CXCL8 | Neutrophil recruitment and activation | CXCL8 overexpression or knockout in neutrophil models |
| TLR4 | Innate immune sensing intersecting with lipoprotein context | TLR4 point-mutation or knockout cells exposed to VLDL particles |
Crystal-induced inflammation and gout biology
The strongest verified disease-relevant link for GO:1905890 comes from the finding that apolipoprotein B-containing lipoproteins are a major regulator of neutrophil responses to monosodium urate crystals. Monosodium urate crystals are the causative agent of gout flares, and neutrophils are key effector cells in that inflammatory process. Because VLDL is an apolipoprotein B-containing lipoprotein, the regulation captured by GO:1905890 may influence how neutrophils respond in crystal-driven inflammation. This makes the term relevant to understanding why lipoprotein context can modify inflammatory intensity.
Metabolic inflammation and immunometabolism
GO:1905890 sits at the interface of lipoprotein metabolism and immune cell regulation. The demonstration that APOB-containing lipoproteins regulate neutrophil responses to monosodium urate crystals supports a model in which metabolic particles tune innate immune behavior. Dysregulation of such crosstalk could contribute to inflammatory states associated with metabolic disease, although the verified citation specifically addresses crystal-induced neutrophil responses. Researchers should therefore frame disease hypotheses around lipoprotein-immune crosstalk rather than overgeneralizing.
Atherosclerosis-adjacent lipoprotein signaling
Apolipoprotein B-containing lipoproteins are central to lipid transport and are well known in cardiovascular biology, and the verified study places them in a regulatory role for neutrophil responses. While the cited work focuses on monosodium urate crystals, it provides a mechanistic precedent that APOB-containing particles can modulate immune cell behavior. This precedent is useful for researchers exploring whether regulation of VLDL responses contributes to vascular inflammatory processes. Any such extension should be tested experimentally rather than assumed.
From regulation of cellular response to very-low-density lipoprotein particle stimulus-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does a candidate gene regulate the cellular response to VLDL particles? | CRISPR knockout in a relevant cell line followed by VLDL particle stimulation |
| Does a specific amino acid change alter regulation of the VLDL response? | Point-mutation knock-in at the candidate residue |
| Does tagging a regulator change its localization during VLDL stimulation? | Tagged knock-in with fluorescent or epitope tag |
| Does increasing a candidate regulator amplify the VLDL response? | Overexpression cell model with dose-controlled induction |
| Which genes modulate neutrophil responses in a lipoprotein context? | CRISPR library screening in neutrophil-like cells with monosodium urate crystal and VLDL co-treatment |
| Is the effect specific to APOB-containing particles? | Comparative stimulation with APOB-containing versus APOB-free lipoprotein preparations |
How to Study the regulation of cellular response to very-low-density lipoprotein particle stimulus Process
| Method | What It Measures | Typical Application |
|---|---|---|
| VLDL particle stimulation assay | Cellular response to a defined VLDL stimulus | Baseline characterization of GO:1905890-related regulation |
| Co-stimulation with monosodium urate crystals | Modulation of inflammatory responses by APOB-containing lipoproteins | Neutrophil regulation studies |
| RNA sequencing | Transcriptional changes during the regulated response | Pathway discovery and candidate gene identification |
| Phosphoproteomics | Signaling amplitude and kinetics | Mapping regulatory nodes in the VLDL response |
| CRISPR knockout | Loss-of-function effect on the response | Causal testing of candidate regulators |
| CRISPR point mutation | Effect of a specific residue on regulation | Structure-function dissection of regulators |
| Tagged knock-in | Localization and dynamics of a regulator | Imaging and interaction studies |
| Overexpression | Gain-of-function effect on the response | Testing sufficiency of a candidate regulator |
Cell-based VLDL stimulation assays
The core method for studying GO:1905890 is a controlled cell-based assay in which cells are exposed to a defined very-low-density lipoprotein particle stimulus and the resulting response is measured. Because apolipoprotein B-containing lipoproteins regulate neutrophil responses to monosodium urate crystals, co-stimulation designs that combine VLDL particles with a second inflammatory trigger can reveal regulatory effects. Readouts should capture frequency, rate, or extent of the response, matching the QuickGO definition. Careful preparation and characterization of the lipoprotein stimulus is essential for reproducibility.
Transcriptomic and pathway profiling
RNA sequencing can identify gene expression programs that change when the cellular response to VLDL particles is modulated. In the context of APOB-containing lipoprotein regulation of neutrophils, transcriptomic readouts can reveal inflammatory and metabolic pathways that respond to the lipoprotein context. Pathway enrichment can then be used to place candidate genes under GO:1905890. Such analyses should be interpreted with the specific stimulus and cell type in mind.
Proteomic and signaling analysis
Phosphoproteomics and targeted signaling assays can measure the amplitude and kinetics of pathways activated during the regulated VLDL response. Because the definition of GO:1905890 includes rate and extent, time-resolved signaling measurements are particularly informative. The verified literature linking APOB-containing lipoproteins to neutrophil regulation provides a rationale for examining inflammatory signaling nodes. Proteomic data should be paired with functional perturbation to establish causality.
CRISPR perturbation and functional validation
CRISPR knockout, point mutation, knock-in, and overexpression can test whether a candidate gene causally regulates the cellular response to VLDL particles. Functional validation is necessary because annotation to GO:1905890 requires demonstrating a change in the frequency, rate, or extent of the response. The neutrophil and crystal-stimulation context from the verified study offers a concrete experimental framework. Combining CRISPR perturbation with the assays above provides the strongest evidence for regulatory roles.
How CRISPR Can Be Used to Study GO:1905890 regulation of cellular response to very-low-density lipoprotein particle stimulus
Knockout
CRISPR knockout is used to remove a candidate regulator and ask whether the cellular response to VLDL particles changes in frequency, rate, or extent. In the context of APOB-containing lipoprotein biology, knockout of APOB or related genes can test the contribution of the lipoprotein particle itself to neutrophil regulation. Knockout models are most informative when paired with a defined VLDL stimulus and a quantitative response readout. This approach directly addresses the causal question implied by GO:1905890.
Point Mutation
Point-mutation knock-in allows researchers to change a single amino acid in a candidate regulator and measure the effect on the VLDL response. This is useful when a domain or residue is hypothesized to mediate regulation of the cellular response. Because GO:1905890 is about modulation rather than binding alone, point mutants should be tested in functional response assays. The verified lipoprotein-neutrophil literature provides a disease-relevant context for such experiments.
Knock-in
Tagged knock-in introduces a reporter or epitope tag into an endogenous locus, enabling visualization and quantification of a regulator during the VLDL response. This helps determine where and when the regulatory process acts within the cell. Knock-in models preserve endogenous regulation better than overexpression and are therefore valuable for GO:1905890 studies. They can be combined with live-cell imaging during VLDL particle stimulation.
Overexpression
Overexpression models test whether increasing the level of a candidate regulator is sufficient to change the cellular response to VLDL particles. This complements knockout by providing gain-of-function evidence. In the context of APOB-containing lipoproteins and neutrophil regulation, overexpression can help establish sufficiency of a regulatory node. Dose-controlled expression systems are preferable to avoid artifacts.
How EDITGENE Supports regulation of cellular response to very-low-density lipoprotein particle stimulus Research
Researchers studying regulation of cellular response to very-low-density lipoprotein particle stimulus-related genes often need to determine whether a candidate gene is causally involved in modulating the frequency, rate, or extent of the cellular response to VLDL particles, rather than merely correlating with it. This requires precise, reproducible cell models in which the candidate gene can be removed, mutated, tagged, or overexpressed and then challenged with a defined VLDL particle stimulus. The verified literature showing that apolipoprotein B-containing lipoproteins regulate neutrophil responses to monosodium urate crystals provides a concrete biological context for such experiments.
Contact EDITGENE today to design your custom CRISPR model for regulation of cellular response to very-low-density lipoprotein particle stimulus research.
Frequently Asked Questions About regulation of cellular response to very-low-density lipoprotein particle stimulus
What is GO:1905890?
GO:1905890 is the Gene Ontology biological_process term for regulation of cellular response to very-low-density lipoprotein particle stimulus, meaning any process that modulates the frequency, rate, or extent of a cell's response to VLDL particles.
What is regulation of cellular response to VLDL particle stimulus?
It is the control layer that determines how strongly, how quickly, and for how long a cell reacts when exposed to a very-low-density lipoprotein particle stimulus.
What genes are involved in regulation of cellular response to very-low-density lipoprotein particle stimulus?
APOB is central because VLDL is an apolipoprotein B-containing lipoprotein, and APOB-containing lipoproteins are a major regulator of neutrophil responses to monosodium urate crystals; other lipoprotein receptors and inflammatory genes are plausible candidates.
Why is GO:1905890 important?
It links lipoprotein metabolism to innate immune regulation, as shown by the ability of APOB-containing lipoproteins to regulate neutrophil responses to monosodium urate crystals.
How do you study regulation of cellular response to very-low-density lipoprotein particle stimulus?
Researchers use defined VLDL particle stimulation assays, often combined with inflammatory co-stimuli, and measure changes in response frequency, rate, or extent using transcriptomic, proteomic, and functional readouts.
What diseases are linked to GO:1905890?
The strongest verified link is to crystal-induced inflammation, because APOB-containing lipoproteins regulate neutrophil responses to monosodium urate crystals, the crystals associated with gout flares.
What is the synonym for GO:1905890?
The synonym is regulation of cellular response to VLDL particle stimulus, using the standard abbreviation VLDL.
Which ontology aspect does GO:1905890 belong to?
GO:1905890 belongs to the biological_process aspect of the Gene Ontology.
Can CRISPR be used to study GO:1905890?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression can test whether a candidate gene causally modulates the cellular response to VLDL particles.
What readouts match the GO:1905890 definition?
Readouts should capture the frequency, rate, or extent of the cellular response to VLDL particles, rather than merely the presence or absence of a response.
Conclusion
GO:1905890, regulation of cellular response to very-low-density lipoprotein particle stimulus, provides a precise ontology label for the control layer that tunes how cells react to VLDL particles. The verified literature showing that apolipoprotein B-containing lipoproteins are a major regulator of neutrophil responses to monosodium urate crystals gives this term a concrete immunometabolic anchor. Researchers can use this framework to design CRISPR-based knockout, point-mutation, knock-in, and overexpression experiments that test causal regulation rather than correlation. As lipoprotein-immune crosstalk continues to attract attention, GO:1905890 will remain a useful term for annotating and interrogating the regulators that shape VLDL-triggered cellular behavior.
References
- 1. Terkeltaub R et al.. 1984. Lipoproteins containing apoprotein B are a major regulator of neutrophil responses to monosodium urate crystals.. J Clin Invest 73(6):1719-30 PMID: 6725556
